D

Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450

Watchlist Manager
Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450
Watchlist
Price: 16 710 KRW 2.26% Market Closed
Market Cap: 734.6B KRW
Have any thoughts about
Dongkook Pharmaceutical Co Ltd?
Write Note

Dongkook Pharmaceutical Co Ltd
Pre-Tax Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Dongkook Pharmaceutical Co Ltd
Pre-Tax Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Pre-Tax Income CAGR 3Y CAGR 5Y CAGR 10Y
D
Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450
Pre-Tax Income
â‚©82.8B
CAGR 3-Years
9%
CAGR 5-Years
3%
CAGR 10-Years
11%
Yuhan Corp
KRX:000100
Pre-Tax Income
â‚©169.6B
CAGR 3-Years
8%
CAGR 5-Years
21%
CAGR 10-Years
4%
SK Biopharmaceuticals Co Ltd
KRX:326030
Pre-Tax Income
-â‚©43.9B
CAGR 3-Years
43%
CAGR 5-Years
20%
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Pre-Tax Income
â‚©226.1B
CAGR 3-Years
29%
CAGR 5-Years
30%
CAGR 10-Years
21%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Pre-Tax Income
â‚©11.9B
CAGR 3-Years
N/A
CAGR 5-Years
-9%
CAGR 10-Years
-2%
C
Celltrion Pharm Inc
KOSDAQ:068760
Pre-Tax Income
â‚©22.4B
CAGR 3-Years
-19%
CAGR 5-Years
39%
CAGR 10-Years
18%
No Stocks Found

Dongkook Pharmaceutical Co Ltd
Glance View

Market Cap
734.7B KRW
Industry
Pharmaceuticals

DongKook Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceuticals. The company is headquartered in Seoul, Seoul. The company went IPO on 2007-05-29. The firm develops and provides remedies for oral troubles, skin troubles and gynecology diseases, contrast mediums, anesthetics, anticancer medicines and circulatory system agents. The company also provides other pharmaceuticals, such as remedies for arthritis and pancreatitis, antiphlogistic, anodynes, antibiotics and vitamins, as well as raw materials for pharmaceuticals. In addition, it is engaged in the rental business. The firm distributes its products within domestic market and to overseas markets, such as Japan, Germany, India, Brazil and Mexico, among others.

Intrinsic Value
19 388.02 KRW
Undervaluation 14%
Intrinsic Value
Price
D

See Also

What is Dongkook Pharmaceutical Co Ltd's Pre-Tax Income?
Pre-Tax Income
82.8B KRW

Based on the financial report for Sep 30, 2024, Dongkook Pharmaceutical Co Ltd's Pre-Tax Income amounts to 82.8B KRW.

What is Dongkook Pharmaceutical Co Ltd's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 10Y
11%

Over the last year, the Pre-Tax Income growth was 38%. The average annual Pre-Tax Income growth rates for Dongkook Pharmaceutical Co Ltd have been 9% over the past three years , 3% over the past five years , and 11% over the past ten years .

Back to Top